Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Point mutations in the presenilin-1 gene (PS1) are a major cause of familial Alzheimer's disease. They result in a selective increase in the production of the amyloidogenic peptide amyloid-beta(1-42) by proteolytic processing of the amyloid precursor protein (APP). Here we investigate whether PS1 is also involved in normal APP processing in neuronal cultures derived from PS1-deficient mouse embryos. Cleavage by alpha- and beta-secretase of the extracellular domain of APP was not affected by the absence of PS1, whereas cleavage by gamma-secretase of the transmembrane domain of APP was prevented, causing carboxyl-terminal fragments of APP to accumulate and a fivefold drop in the production of amyloid peptide. Pulse-chase experiments indicated that PS1 deficiency specifically decreased the turnover of the membrane-associated fragments of APP. As in the regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor, PS1 appears to facilitate a proteolytic activity that cleaves the integral membrane domain of APP. Our results indicate that mutations in PS1 that manifest clinically cause a gain of function and that inhibition of PS1 activity is a potential target for anti-amyloidogenic therapy in Alzheimer's disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Aβ is produced by sequential β- and γ-secretase proteolytic cleavage of the amyloid precursor protein (APP) [11–17].”
From Amyloid-β interrupts canonical Sonic hedgehog signaling by distorting primary cilia structure (2018) · cites this paper as [13]
In the citing paper
“The three major APOE variants, APOE2, APOE3, and APOE4, differ from each other at two amino acid positions, 112 and 158, and modulate AD risk. E3 is the most common APOE variant and is considered neutral with regards to AD risk, while E4 alleles elevate AD risk and E2 reduces AD risk12,13.”
From APOE3 - R136S mutation confers resilience against tau pathology via cGAS-STING-IFN inhibition (2024) · cites this paper as [12]
In the citing paper
“knocking out the gene results in decreased production of both βA4(1-40) and (1-42) amyloid peptides (De Strooper et al. 1998).”
From Presenilin 1 Controls γ-Secretase Processing of Amyloid Precursor Protein in Pre-Golgi Compartments of Hippocampal Neurons (1999) · cites this paper as De Strooper et al. 1998
In the citing paper
“Mutations of presenilin 1 (PS1) causing Alzheimer's disease selectively increase the secretion of the amyloidogenic βA4(1-42)”
From Presenilin 1 Controls γ-Secretase Processing of Amyloid Precursor Protein in Pre-Golgi Compartments of Hippocampal Neurons (1999) · cites this paper as De Strooper et al. 1998
In the citing paper
“As β- (and α-) clipping was virtually normal in neurons derived from those animals, the effect on APP processing is confined to γ-secretase activities (De Strooper et al. 1998).”
From Presenilin 1 Controls γ-Secretase Processing of Amyloid Precursor Protein in Pre-Golgi Compartments of Hippocampal Neurons (1999) · cites this paper as De Strooper et al. 1998
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051
Brown, M. S., & Goldstein, J. L. (1997) · Cell · doi:10.1016/s0092-8674(00)80213-5 · Cited by 3,834 · cited 1×
“As in the regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription facto”
BackgroundScheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-864 · Cited by 2,599
Amyloid β-peptide is produced by cultured cells during normal metabolism
Haass, C., Schlossmacher, M. G., Hung, A. Y., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, B. L., Lieberburg, I., Koo, E. H., Schenk, D., Teplow, D. B., et al. (1992) · Nature · doi:10.1038/359322a0 · Cited by 1,921 · cited 1×
“This was confirmed using antibodies against amino-acid residues 595–612 (R1736”
MethodAmyloid, the presenilins and Alzheimer’s disease
Hardy, J. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)01030-2 · Cited by 1,370
Citron, M., Westaway, D., Xia, W., Carlson, G., Diehl, T., Levesque, G., Johnson-wood, K., Lee, M., Seubert, P., Davis, A., et al. (1997) · Nature Medicine · doi:10.1038/nm0197-67 · Cited by 1,271
Skeletal and CNS Defects in Presenilin-1-Deficient Mice
Shen, J., Bronson, R. T., Chen, D. F., Xia, W., Selkoe, D. J., & Tonegawa, S. (1997) · Cell · doi:10.1016/s0092-8674(00)80244-5 · Cited by 959
Presenilin 1 is required for Notch 1 and Dll1 expression in the paraxial mesoderm
Wong, P. C., Zheng, H., Chen, H., Becher, M. W., Sirinathsinghji, D. J. S., Trumbauer, M. E., Chen, H. Y., Price, D. L., Van der Ploeg, L. H. T., & Sisodia, S. S. (1997) · Nature · doi:10.1038/387288a0 · Cited by 711
Distinct sites of intracellular production for Alzheimer's disease Aβ40/42 amyloid peptides
Hartmann, T., Bieger, S. C., Brühl, B., Tienari, P. J., Ida, N., Allsop, D., Roberts, G. W., Masters, C. L., Dotti, C. G., Unsicker, K., et al. (1997) · Nature Medicine · doi:10.1038/nm0997-1016 · Cited by 709
Cellular processing of β-amyloid precursor protein and the genesis of amyloid β-peptide
Haass, C., & Selkoe, D. J. (1993) · Cell · doi:10.1016/0092-8674(93)90312-e · Cited by 686
Cited by
Items 801–900 of 1,008
Alcohol Use Disorder and Dementia: A Review
Zahr, N. M. (2024) · Alcohol research · doi:10.35946/arcr.v44.1.03 · Cited by 51
Structural Biology of Presenilins and Signal Peptide Peptidases
Tomita, T., & Iwatsubo, T. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.r113.463281 · Cited by 46
Vandersteen, A., Masman, M. F., Baets, G. D., Jonckheere, W., van der Werf, K., Marrink, . J., Rozenski, J., Benilova, I., Strooper, B. D., Subramaniam, V., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.394635 · Cited by 58
Somavarapu, A. K., & Kepp, K. P. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.02.008 · Cited by 45
“…1993; Haass et al., 2012). γ-Secretase is a protein complex consisting of four parts: presenilin (PSEN), nicastrin (NCT), presenilin enhancer 2 (PEN2), and anterior pharynx-defective 1 (APH1); of these, PSEN is the catalytic subunit of γ-secretase (Kimberly et al., 2003; De Strooper et al., 1998).”
BackgroundPeripheral and central effects of γ-secretase inhibition by semagacestat in Alzheimer’s disease
Doody, R. S., Raman, R., Sperling, R. A., Seimers, E., Sethuraman, G., Mohs, R., Farlow, M., Iwatsubo, T., Vellas, B., Sun, X., et al. (2015) · Alzheimer's Research & Therapy · doi:10.1186/s13195-015-0121-6 · Cited by 43
“familial autosomal dominant AD involve presenilin, a γ-secretase component [3].”
BackgroundA novel substrate for analyzing Alzheimer's disease γ‐secretase
Lichtenthaler, S. F., Multhaup, G., Masters, C. L., & Beyreuther, K. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00730-9 · Cited by 47
Synthesis of some N-alkyl substituted urea derivatives as antibacterial and antifungal agents
Zheng, Q., Cheng, K., Zhang, X., Liu, K., Jiao, Q., & Zhu, H. (2010) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2010.03.027 · Cited by 46
Functional and Topological Analysis of Pen-2, the Fourth Subunit of the γ-Secretase Complex
Bammens, L., Chávez‐Gutiérrez, L., Tolia, A., Zwijsen, A., & Strooper, B. D. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.216978 · Cited by 55
RetractedThe Presenilin-2 Loop Peptide Perturbs Intracellular Ca2+ Homeostasis and Accelerates Apoptosis
Cai, C., Lin, P., Cheung, K., Li, N., Levchook, C., Pan, Z., Ferrante, C., Boulianne, G. L., Foskett, J. K., Danielpour, D., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512026200 · Cited by 46
Maldonado, T. A., Jones, R. E., & Norris, D. O. (2000) · Brain Research · doi:10.1016/s0006-8993(99)02328-8 · Cited by 53
Refolo, L. M., Eckman, C., Prada, C.-M., Yager, D., Sambamurti, K., Mehta, N. D., Hardy, J., & Younkin, S. G. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0732383.x · Cited by 51
“…PS1 knockout mice appears to show that loss of presenilin function was associated with a reduction in the production of Ab (Davis et al., 1998; De Strooper et al., 1998; Qian et al., 1998), resulting in the hypothesis that presenilin mutations lead to disease through a gain of function mechanism.”
Wang, H., Luo, W.-J., Zhang, Y.-W., Li, Y.-M., Thinakaran, G., Greengard, P., & Xu, H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404345200 · Cited by 47
Lemberg, M. K., & Martoglio, B. (2004) · FEBS Letters · doi:10.1016/s0014-5793(04)00192-9 · Cited by 50
Theuns, J. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg098 · Cited by 46
“On the other hand, in neuronal cell cultures derived from PSEN1 deficient mice, APP processing into Ab was prevented (12).”
BackgroundAyton, S., & Bush, A. I. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101212 · Cited by 45
Tau hyperphosphorylation and increased BACE1 and RAGE levels in the cortex of PPARβ/δ-null mice
Barroso, E., del Valle, J., Porquet, D., Vieira Santos, A. M., Salvadó, L., Rodríguez-Rodríguez, R., Gutiérrez, P., Anglada-Huguet, M., Alberch, J., Camins, A., et al. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.03.006 · Cited by 42
Zhao, X. D., Liu, C., Xu, M., Li, X., Bi, K., & Jia, Y. (2016) · PLoS ONE · doi:10.1371/journal.pone.0152772 · Cited by 50
“Two proteases contribute to the hydrolysis of APP, referred to γ- and β-secretase (β-site amyloid precursor protein cleaving enzyme 1, BACE1). γ-secretase cleaves a short C-terminal fragment of APP [11], and β-secretase cleaves in the ectodomain of APP at the N-terminus of the Aβ domain [12], which both lead to Aβ sec…”
BackgroundInfluentialLatest emerging functions of SPP/SPPL intramembrane proteases
Mentrup, T., Fluhrer, R., & Schröder, B. (2017) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2017.03.002 · Cited by 43
“…(FAD) (Cruts et al., 1996), meanwhile more than 100 different presenilin/γ-secretase substrates, among them the amyloid precursor protein (APP) (De Strooper et al., 1998) and the Notch receptor (De Strooper et al., 1999) were described (Haapasalo and Kovacs, 2011; Jurisch-Yaksi et al., 2013).”
BackgroundBidirectional regulation of Aβ levels by Presenilin 1
Bustos, V., Pulina, M. V., Kelahmetoglu, Y., Sinha, S. C., Gorelick, F. S., Flajolet, M., & Greengard, P. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1705235114 · Cited by 49
“Aβ is generated through sequential proteolysis of the amyloid precursor protein (APP), first by β-secretase, producing βCTF, and then by the γ-secretase complex, generating Aβ (2, 3).”
BackgroundCulvenor, J. G., Evin, G. M., Cooney, M. A., Wardan, H., Sharples, R. A., Maher, F., Reed, G., Diehlmann, A., Weidemann, A., Beyreuther, K. T., et al. (2000) · Experimental Cell Research · doi:10.1006/excr.1999.4791 · Cited by 51
Alzheimer's presenilin 1 is a putative membrane receptor for rab GDP dissociation inhibitor
Scheper, W., Zwart, R., van der Sluijs, P., Annaert, W., Gool, W. A., & Baas, F. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.2.303 · Cited by 52
Self-citationDe Jonghe, C., Cras, P., Vanderstichele, H., Cruts, M., Vanderhoeven, I., Smouts, I., Vanmechelen, E., Martin, J.-J., Hendriks, L., & Van Broeckhoven, C. (1999) · Neurobiology of Disease · doi:10.1006/nbdi.1999.0247 · Cited by 45
Self-citationMartys, J. L., Kim, S., Berechid, B. E., Bingham, S. J., Chu, S., Sklar, J., Nye, J. S., & Sisodia, S. S. (2000) · Journal of Molecular Neuroscience · doi:10.1385/jmn:15:3:189 · Cited by 48
“Definitive evidence supporting a role for PS1 in production of Aβ peptides emerged with the observation that cells lacking PS1 fail to secrete Aβ peptides, commensurate with the intracellular accumulation of APP carboxyl-terminal fragments (CTFs) (DeStrooper et al., 1998; Naruse et al., 1998).”
BackgroundSynaptotagmins interact with APP and promote Aβ generation
Gautam, V., D’Avanzo, C., Berezovska, O., Tanzi, R. E., & Kovacs, D. M. (2015) · Molecular Neurodegeneration · doi:10.1186/s13024-015-0028-5 · Cited by 43
“In the amyloidogenic processing, BACE1 first generates βCTF that is further processed by the γ-secretase complex to produce pathogenic Aβ peptides and AICD fragments [9–15].”
BackgroundSuárez‐Calvet, M., Belbin, O., Pera, M., Badiola, N., Magrané, J., Guardia‐Laguarta, C., Muñoz, L., Colom‐Cadena, M., Clarimón, J., & Lleó, A. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12466 · Cited by 41
“(2014) 128, 330--339 PSEN1 and PSEN2, although PSEN1/c- secretase-containing complexes are the major contributors to Ab production in the CNS (De Strooper et al. 1998; Franberg et al. 2011; Borgegard et al. 2012).”
BackgroundBorgegård, T., Gustavsson, S., Nilsson, C., Parpal, S., Klintenberg, R., Berg, A.-L., Rosqvist, S., Serneels, L., Svensson, S., Olsson, F., et al. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.1451-12.2012 · Cited by 43
“The PS proteins constitute the enzymatic moiety of -secretase and are the molecular targets of established classes of -secretase inhibitors (GSIs) (De Strooper et al., 1998; Morohashi et al., 2006).”
McMains, V. C., Myre, M. A., Kreppel, L. K., & Kimmel, A. R. (2010) · Disease Models & Mechanisms · doi:10.1242/dmm.004457 · Cited by 48
“…Wolfe et al., 1999), an unusual membrane aspartyl protease that cleaves a wide variety of type 1 (single-pass) integral membrane proteins (Steiner et al., 2008) within their transmembrane (TM) domains to modulate cell signaling (De Strooper et al., 1999; De Strooper et al., 1998; Kim et al., 2005).”
BackgroundTwo novel mutations of the NCSTN gene in Chinese familial acne inverse
Zhang, C., Wang, L., Chen, L., Ren, W., Mei, A., Chen, X., & Deng, Y. (2012) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2012.04627.x · Cited by 44
Age‐related changes of intracellular Aβ in cynomolgus monkey brains
Kimura, N., Yanagisawa, K., Terao, K., Ono, F., Sakakibara, I., Ishii, Y., Kyuwa, S., & Yoshikawa, Y. (2005) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2004.00624.x · Cited by 44
Schenk, D., Games, D., & Seubert, P. (2001) · Journal of Molecular Neuroscience · doi:10.1385/jmn:17:2:259 · Cited by 48
“Evidence to support this hypothesis included the effect of presenilin mutations on Aβ peptide production, and the fact that the knockout of the presenilin genes reduces or abolishes γ-secretase activity (De Strooper et al., 1998; Steiner et al., 1999).”
BackgroundSecretases as targets for the treatment of Alzheimer’s disease
Citron, M. (2000) · Molecular Medicine Today · doi:10.1016/s1357-4310(00)01759-7 · Cited by 53
The Amyloid Cascade Hypothesis
Castellani, R. J., Jamshidi, P., Plascencia‐Villa, G., & Perry, G. L. (2024) · American Journal Of Pathology · doi:10.1016/j.ajpath.2024.10.014 · Cited by 46
Orejana, L., Barros-Miñones, L., Jordán, J., Cedazo-Mínguez, Á., Tordera, R. M., Aguirre, N., & Puerta, E. (2014) · The Journals of Gerontology Series A · doi:10.1093/gerona/glu106 · Cited by 46
“hippocampal cell death, neuroinflammation and oxidative stress following amyloid-β(1-40) administration in mice: evidence for disso-”
BackgroundRaj, D. B. T. G., Ghesquière, B., Tharkeshwar, A. K., Coen, K., Derua, R., Vanderschaeghe, D., Rysman, E., Bagadi, M., Baatsen, P., Strooper, B. D., et al. (2011) · Molecular Systems Biology · doi:10.1038/msb.2011.74 · Cited by 43
Self-citationKim, H., Ki, H., Park, H.-S., & Kim, K. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502769200 · Cited by 43
Sun, X., Beglopoulos, V., Mattson, M. P., & Shen, J. (2005) · Neurodegenerative Diseases · doi:10.1159/000086426 · Cited by 48
“PS1 is a transmembrane protein required for the γ-secretase activity responsible for the proteolytic cleavage of the amyloid precursor protein (APP) and Notch [”
p53 Is Regulated by and Regulates Members of the γ-Secretase Complex
Checler, F., Dunys, J., Pardossi-Piquard, R., & Alves da Costa, C. (2010) · Neurodegenerative Diseases · doi:10.1159/000283483 · Cited by 39
Liu, C.-X., Ranganathan, S., Robinson, S., & Strickland, D. K. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608088200 · Cited by 43
Uemura, K., Kitagawa, N., Kohno, R., Kuzuya, A., Kageyama, T., Shibasaki, H., & Shimohama, S. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10641 · Cited by 46
“Ablation of PS1 results in a signif- icant reduction in amyloid -peptide generation (De Strooper et al., 1998).”
BackgroundNeuropathology and treatment of Alzheimer disease: did we lose the forest for the trees?
Castellani, R. J., Zhu, X., Lee, H., Moreira, P. I., Perry, G. L., & Smith, M. A. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.5.473 · Cited by 48
Mann, D. M. A., Takeuchi, A., Sato, S., Cairns, N. J., Lantos, P. L., Rossor, M. N., Haltia, M., Kalimo, H., & Iwatsubo, T. (2001) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2001.00316.x · Cited by 42
Presenilin and γ‐secretase: structure meets function
Wolfe, M. S. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00245.x · Cited by 51
“…milestone was the ®nding that knockout of PS1 in mice caused a dramatic reduction in g-secretase processing of APP without apparent affect on APP maturation or subcellular distribution (De Strooper et al. 1998), suggesting that presenilins mediate most, if not all, proteolysis by g-secretase.”
BackgroundThe role of Smo-Shh/Gli signaling activation in the prevention of neurological and ageing disorders
Prajapati, A., Mehan, S., & Khan, Z. (2023) · Biogerontology · doi:10.1007/s10522-023-10034-1 · Cited by 43
Pro198Leu polymorphism affects the selenium status and GPx activity in response to Brazil nut intake
Cardoso, B. R., Busse, A. L., Hare, D. J., Cominetti, C., Horst, M. A., McColl, G., Magaldi, R. M., Filho, W. J., & Cozzolino, S. M. F. (2016) · Food & Function · doi:10.1039/c5fo01270h · Cited by 44
Presenilin 1 Independently Regulates β-Catenin Stability and Transcriptional Activity
Killick, R., Pollard, C. C., Asuni, A. A., Mudher, A. K., Richardson, J. C., Rupniak, H. T., Sheppard, P. W., Varndell, I. M., Brion, J.-P., Levey, A. I., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m108332200 · Cited by 41
Presenilin 1 in migration and morphogenesis in the central nervous system
Louvi, A., Sisodia, S. S., & Grove, E. A. (2004) · Development · doi:10.1242/dev.01191 · Cited by 43
“…evidence has accumulated supporting a role for Psen1 in intramembranous, ‘γ-secretase’ processing not only of the β-amyloid precursor protein (APP) (De Strooper et al., 1998; Naruse et al., 1998), but also an increasing list of various type I membrane proteins, including Notch1 (De Strooper et…”
BackgroundOctave, J.-N., Essalmani, R., Tasiaux, B., Menager, J., Czech, C., & Mercken, L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.3.1525 · Cited by 42
Tomita, S., Kirino, Y., & Suzuki, T. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.30.19304 · Cited by 42
Toward Alzheimer Therapies Based on Genetic Knowledge
Hardy, J. (2004) · Annual Review of Medicine · doi:10.1146/annurev.med.55.091902.103607 · Cited by 44
Stanga, S., Boido, M., & Kienlen‐Campard, P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010136 · Cited by 42
Loss of presenilin function is associated with a selective gain of APP function
Deyts, C., Clutter, M., Herrera, S., Jovanovic, N., Goddi, A., & Parent, A. T. (2016) · eLife · doi:10.7554/elife.15645 · Cited by 41
“…that inhibition of g-secretase activity, or lack of presenilin 1 (PS1) expression, produces an endogenous accumulation of APP-CTF in the brain, neuronal cultures, or cell lines (Bentahir et al., 2006; De Strooper et al., 1998; Parent et al., 2005; Walker et al., 2005; Woodruff et al., 2013).”
Regulated intramembrane proteolysis: emergent role in cell signalling pathways
McCarthy, A. J., Coleman-Vaughan, C., & McCarthy, J. V. (2017) · Biochemical Society Transactions · doi:10.1042/bst20170002 · Cited by 46
Raman, S., Brookhouser, N., & Brafman, D. A. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104788 · Cited by 42
Behbahani, H., Shabalina, I. G., Wiehager, B., Concha, H., Hultenby, K., Petrovic, N., Nedergaard, J., Winblad, B., Cowburn, R. F., & Ankarcrona, M. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.20990 · Cited by 42
“PS1 is responsible for the major g-secretase activity generating Ab and the absence of PS1 results in accumulation of uncleaved APP (De Strooper et al., 1998).”
BackgroundKirby, J., Heath, P. R., Shaw, P. J., & Hamdy, F. C. (2007) · Advances in clinical chemistry · doi:10.1016/s0065-2423(07)44008-2 · Cited by 47
Green, A. J. E. (2002) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2002.t01-2-00427.x · Cited by 45
Amyloid, Presenilins, and Alzheimer’s Disease
Gassen, G. V., & Annaert, W. (2003) · The Neuroscientist · doi:10.1177/1073858403252227 · Cited by 41
Self-citationAlzheimer's Disease Modeling: Ups, Downs, and Perspectives for Human Induced Pluripotent Stem Cells
Wojda, U., & Kuznicki, J. (2013) · Journal of Alzheimer's Disease · doi:10.3233/jad-121984 · Cited by 39
“Together with -secretase, another protease, they are responsible for the release of A peptide from A PP [14, 15].”
Ca2+ dysfunction in neurodegenerative disorders: Alzheimer's disease
Fedrizzi, L., & Carafoli, E. (2011) · BioFactors · doi:10.1002/biof.157 · Cited by 45
Gibson, G. E., & Thakkar, A. (2017) · Neurochemical Research · doi:10.1007/s11064-017-2182-3 · Cited by 39
“Oxidants, APP mutations, trisomy 21 Oxidants, PS1, PS2 mutations”
InfluentialAssociation of GPX1 and GPX4 polymorphisms with episodic memory and Alzheimer’s disease
da Rocha, T. J., Alves, M. S., Guisso, C. C., de Andrade, F. M., Camozzato, A. L., de Oliveira, A. A., & Fiegenbaum, M. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.12.026 · Cited by 40
Copper homeostasis and the ubiquitin proteasome system
Zhang, B., & Burke, R. (2023) · Metallomics · doi:10.1093/mtomcs/mfad010 · Cited by 43
Presenilin-1 Dependent Neurogenesis Regulates Hippocampal Learning and Memory
Bonds, J. A., Kuttner-Hirshler, Y., Bartolotti, N., Tobin, M. K., Pizzi, M., Marr, R., & Lazarov, O. (2015) · PLOS ONE · doi:10.1371/journal.pone.0131266 · Cited by 38
Yan, X.-X., Li, T., Rominger, C. M., Prakash, S. R., Wong, P. C., Olson, R. E., Zaczek, R. C., & Li, Y.-W. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.0092-04.2004 · Cited by 42
Gene Dosage Effect on γ-Secretase Component Aph-1b in a Rat Model for Neurodevelopmental Disorders
Coolen, M. W., van Loo, K. M. J., van Bakel, N. H. M., Pulford, D. J., Serneels, L., Strooper, B. D., Ellenbroek, B. A., Cools, A. R., & Martens, G. J. M. (2005) · Neuron · doi:10.1016/j.neuron.2004.12.054 · Cited by 44
γ-Secretase Inhibitors as Molecular Probes of Presenilin Function
Wolfe, M. S. (2001) · Journal of Molecular Neuroscience · doi:10.1385/jmn:17:2:199 · Cited by 48
“…Greenwald, 1995), and knockout of presenilin-1 in mice is lethal in utero with a phenotype similar to that caused by a Notch1 deficiency (Shen et al., 1997; Wong et al., 1997); and 3) presenilin-1 knockout cells showed dramatically reduced γ-secretase processing of APP (De Strooper et al., 1998).”
BackgroundIkeuchi, T., Dolios, G., Kim, S.-H., Wang, R., & Sisodia, S. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209252200 · Cited by 39
Petanceska, S. S., Seeger, M., Checler, F., & Gandy, S. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0741878.x · Cited by 32
Vrièze, F. W., Crook, R., Holmans, P., Kehoe, P. G., Owen, M. J., Williams, J. H., Roehl, K., Lahiri, D. K., Shears, S., Booth, J., et al. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00417-6 · Cited by 40
Roßner, S., Beck, M., Stahl, T., Mendla, K., Schliebs, R., & Bigl, V. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00211.x · Cited by 41
Ma, D., Stokes, K., Mahngar, K., Domazet-Damjanov, D., Sikorska, M., & Pandey, S. (2014) · Mitochondrion · doi:10.1016/j.mito.2014.07.004 · Cited by 39
“The transmembrane protein PS-1 in particular, responsible for the development of AD familial type 3 when its gene is mutated, is a component of the γ-secretase complex responsible for APP processing to the amyloid-beta peptide (Aβ) (Citron et al., 1997; De Strooper et al., 1998).”
BackgroundZhang, S.-S., Gao, Z., Feng, L., & Li, M. (2024) · Journal of Inflammation Research · doi:10.2147/jir.s483412 · Cited by 40
Structural and mechanistic principles of intramembrane proteolysis – lessons from rhomboids
Stříšovský, K. (2013) · FEBS Journal · doi:10.1111/febs.12199 · Cited by 39
Picón-Pagès, P., Bonet, J., García-García, J., Garcia-Buendia, J., Gutierrez, D., Valle, J., Gómez-Casuso, C. E. S., Sidelkivska, V., Alvarez, A., Perálvarez-Marín, A., et al. (2019) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2019.06.017 · Cited by 37
“The Aβ is a ~4 kDa peptide released from the amyloid precursor protein (APP) [6] by the sequential action of the enzymes β- and γsecretases [7,8].”
Backgroundvan den Heuvel, C., Donkin, J. J., Finnie, J. W., Blumbergs, P. C., Kuchel, T. R., Koszyca, B., Manavis, J., Jones, N. R., Reilly, P. L., & Vink, R. (2004) · Journal of Neurotrauma · doi:10.1089/0897715042441783 · Cited by 43
Overexpression of calsenilin enhances γ-secretase activity
Jo, D., Jang, J., Kim, B.-J., Lundkvist, J., & Jung, Y. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2004.12.078 · Cited by 43
Muyllaert, D., Terwel, D., Borghgraef, P., Devijver, H., Dewachter, I., & Leuven, F. V. (2006) · Revue Neurologique · doi:10.1016/s0035-3787(06)75098-6 · Cited by 44
Mutant Presenilin 1 Alters Synaptic Transmission in Cultured Hippocampal Neurons
Priller, C., Dewachter, I., Vassallo, N., Paluch, S., Pace, C., Kretzschmar, H. A., Van Leuven, F., & Herms, J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m605066200 · Cited by 37
Chen, F., Tandon, A., Sanjo, N., Gu, Y., Hasegawa, H., Arawaka, S., Lee, F. J. S., Ruan, X., Mastrangelo, P., Erdebil, S., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210049200 · Cited by 39
Coughlan, C. M., & Breen, K. C. (2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(00)00036-x · Cited by 45
Cellular and molecular basis of b-amyloid precursor protein metabolism (Y2K update)
Greenfield, J. (2000) · Frontiers in Bioscience · doi:10.2741/greenfield · Cited by 38
Inhibiting Amyloid Precursor Protein C-terminal Cleavage Promotes an Interaction with Presenilin 1
Verdile, G., Martins, R. N., Duthie, M., Holmes, E., George‐Hyslop, P. S., & Fraser, P. E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000208200 · Cited by 43
Allosteric Modulation of Intact γ-Secretase Structural Dynamics
Lee, J. Y., Feng, Z., Xie, X., & Bahar, İ. (2017) · Biophysical Journal · doi:10.1016/j.bpj.2017.10.012 · Cited by 42
Presenilin/γ-Secretase Cleaves CD46 in Response to Neisseria Infection
Weyand, N. J., Calton, C. M., Higashi, D. L., Kanack, K. J., & So, M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900522 · Cited by 38
“Cells expressing DN PS1 or PS2 mutant constructs cannot process APP or Notch (48, 67).”
BackgroundInfluentialAPH1 Polar Transmembrane Residues Regulate the Assembly and Activity of Presenilin Complexes
Pardossi‐Piquard, R., Yang, S., Kanemoto, S., Gu, Y., Chen, F., Böhm, C., Sévalle, J., Li, T., Wong, P. C., Checler, F., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.000067 · Cited by 38
Sai, X., Kokame, K., Shiraishi, H., Kawamura, Y., Miyata, T., Yanagisawa, K., & Komano, H. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)01009-3 · Cited by 38
Butterfield, D. A., & Owen, J. B. (2010) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201000070 · Cited by 39
Traffic jam hypothesis: Relationship between endocytic dysfunction and Alzheimer's disease
Kimura, N., & Yanagisawa, K. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2017.07.002 · Cited by 36
Wen, C., Levitan, D. J., Li, X., & Greenwald, I. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.011446498 · Cited by 41
Age-related changes in the localization of presenilin-1 in cynomolgus monkey brain
Kimura, N., Nakamura, S., Honda, T., Takashima, A., Nakayama, H., Ono, F., Sakakibara, I., Doi, K., Kawamura, S., & Yoshikawa, Y. (2001) · Brain Research · doi:10.1016/s0006-8993(01)03146-8 · Cited by 40
Tang, Y., Yamada, K., Kanou, Y., Miyazaki, T., Xiong, X., Kambe, F., Murata, Y., Seo, H., & Nabeshima, T. (2000) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00158-3 · Cited by 39
Calsenilin regulates presenilin 1/γ‐secretase‐mediated N‐cadherin ∊‐cleavage and β‐catenin signaling
Jang, C., Choi, J., Na, Y., Jang, B., Wasco, W., Buxbaum, J. D., Kim, Y., & Choi, E. (2011) · The FASEB Journal · doi:10.1096/fj.11-185926 · Cited by 35
“PS1 mediates classic -secretase cleavages of -APP to generate A , a major component of senile plaques (14).”
BackgroundWrigley, J. D. J., Schurov, I., Nunn, E. J., Martin, A. C. L., Clarke, E. E., Ellis, S., Bonnert, T. P., Shearman, M. S., & Beher, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m413086200 · Cited by 38
Notch 1 interacts with the amyloid precursor protein in a Numb‐independent manner
Fassa, A., Mehta, P. D., & Efthimiopoulos, S. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20642 · Cited by 37
“…of C83 by g-secretase, a multiprotein enzymatic complex (Fraser et al., 2000) in which presenilin 1 (PS1) contributes to the active site (De Strooper et al., 1998; Wolfe et al., 1999; Shearman et al., 2000) within its transmembrane domain releases the p3 fragment or APP intracellular…”
BackgroundPalacino, J. J., Murphy, M. P., Murayama, O., Iwasaki, K., Fujiwara, M., Takashima, A., Golde, T. E., & Wolozin, B. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105376200 · Cited by 35
Yuasa, S., Nakajima, M., Aizawa, H., Sahara, N., Koizumi, K., Sakai, T., Usami, M., Kobayashi, S., Kuroyanagi, H., Mori, H., et al. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10430 · Cited by 37
“PS-1 has recently been suggested to be involved in the processing of two membrane proteins, amyloid precursor protein (APP) and Notch-1 (De Strooper et al., 1998, 1999; Wolfe et al., 1999).”
BackgroundOkochi, M., Eimer, S., Böttcher, A., Baumeister, R., Romig, H., Walter, J., Capell, A., Steiner, H., & Haass, C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005254200 · Cited by 40
Wilson, C. A., Doms, R. W., & Lee, V. M. ‐. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10776 · Cited by 38
“Concomitantly, there is an accumulation of pre- - cleavage APP carboxy-terminal fragments (CTFs), suggesting that the blockade of A production occurs at the level of -secretase (De Strooper et al., 1998; Naruse et al., 1998).”
BackgroundResultDe Strooper, B., & Karran, E. (2024) · The EMBO Journal · doi:10.1038/s44318-024-00057-w · Cited by 36
“Presenilins PSEN1 and PSEN2 provide the catalytic cores to the different γ -secretases (De Strooper et al, 1998; Struhl and Green-wald, 1999; De Strooper et al, 1999; Wolfe et al, 1999; Li et al, 2000).”
Background
Metadata
- Authors
- De Strooper, B., Saftig, P., Craessaerts, K., Vanderstichele, H., Guhde, G., Annaert, W., Von Figura, K., & Van Leuven, F.
- Affiliations
- Vlaams Instituut voor Biotechnologie (BE)
- University of Göttingen (DE)
- Venue
- Nature
- Published
- 1998-01
- Volume
- 391
- Issue
- 6665
- Pages
- 387-390
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1655404681
- Cited by
- 1,818
- References
- 30
- Citations by year
- 2026: 19 · 2025: 39 · 2024: 47 · 2023: 42 · 2022: 33 · 2021: 35 · 2020: 53 · 2019: 43 · 2018: 36 · 2017: 58 · 2016: 60 · 2015: 43 · 2014: 55 · 2013: 64 · 2012: 71
- FWCI
- 76.15
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- presenilin 1, amyloid precursor protein, APP processing, gamma-secretase, amyloid-beta 42, Alzheimer's disease, familial Alzheimer's disease, carboxyl-terminal fragment, gain-of-function, membrane proteolysis
- MeSH terms
- Animals, Cells, Cultured, Humans, Membrane Proteins, Neurons, Peptide Fragments, Endopeptidases, Protein Processing, Post-Translational, Amyloid beta-Peptides, Aspartic Acid Endopeptidases, Amyloid beta-Protein Precursor, Point Mutation, Mice, Presenilin-1, Amyloid Precursor Protein Secretases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.